The Rise and Fall of NMDA Antagonists for Ischemic Stroke
Journal:
Current Molecular Medicine
Volume:
4
Page:
131-136
Author(s):
L. Hoyte, P. A. Barber, A. M. Buchan and M. D. Hill
Molecular Mechanisms Underlying Specificity of Excitotoxic Signaling in Neurons
Journal:
Current Molecular Medicine
Volume:
4
Page:
137-147
Author(s):
Michelle M. Aarts and Michael Tymianski
Nitric Oxide and its Role in Ischaemic Brain Injury
Journal:
Current Molecular Medicine
Volume:
4
Page:
179-191
Author(s):
Robert G. Keynes and John Garthwaite
Astrocyte Influences on Ischemic Neuronal Death
Journal:
Current Molecular Medicine
Volume:
4
Page:
193-205
Author(s):
Raymond A. Swanson, Weihai Ying and Tiina M. Kauppinen
What have Genetically Engineered Mice Taught Us About Ischemic Injury?
Journal:
Current Molecular Medicine
Volume:
4
Page:
207-225
Author(s):
Dong Liang, Ted M. Dawson and Valina L. Dawson
Genes, Environment, Intermediate Phenotypes, and the Pathogenesis of Diabetic Nephropathy
Journal:
Current Pharmacogenomics
Volume:
2
Page:
61-74
Author(s):
M. C. Lansang and N. K. Hollenberg
Candidate Genes in the Pharmacogenomics of Antihypertensive Treatment - A Review and Future Aspects
Journal:
Current Pharmacogenomics
Volume:
2
Page:
83-112
Author(s):
P. Hallberg and H. Melhus
Preface
Journal:
Vascular Disease Prevention (Discontinued)
Volume:
1
Page:
i-i
Author(s):
D. P. Mikhailidis
Pharmacotherapy for Intermittent Claudication: From Consensus-Based to Evidence-Based Treatment
Journal:
Vascular Disease Prevention (Discontinued)
Volume:
1
Page:
1-15
Author(s):
Roberto Antonio Mangiafico and Carmelo Erio Fiore
Atherosclerotic Plaque Stabilization - Potential Role for Immunomodulatory Therapy
Journal:
Vascular Disease Prevention (Discontinued)
Volume:
1
Page:
17-31
Author(s):
Jan Kristian Damas, Torgun Waehre, Arne Yndestad, Lars Gullestad and Pal Aukrust